Research Focus

Former Employee. SKI Surgery; Senior Research Scientist

Recent additions – View all

1. Potent antitumor activity of MLN0128, an investigational selective mTORC1/2 kinase inhibitor, in preclinical models of rhabdomyosarcoma

   Meeting Abstract

   Slotkin, E.; Patwardhan, P.; Deraje, S. V. ; Schwartz, G.; Tap, W.
   Cancer Research (2014)

   Fulltext@MSK | Save
2. BIBF1120, an investigational triple angiokinase inhibitor, in combination with inhibitors of mTOR signaling shows potent antitumor activity in preclinical models of sarcoma

   Meeting Abstract

   Patwardhan, P. P.; Musi, E.; Ivy, K. S.; Giovino, N.; Schwartz, G. K.
   Cancer Research (2014)

   Fulltext@MSK | Save
3. Preclinical development of a novel multi-targeted kinase inhibitor, MG516, for the treatment of sarcoma

   Meeting Abstract

   Ivy, K. S.; Patwardhan, P. P.; Schwartz, G. K.
   Cancer Research (2014)

   Fulltext@MSK | Save